OLD DRUGS - OLD PEOPLE - NEW INSIGHTS

被引：0
作者：
Sitar, Daniel S. [1 ]
机构：
[1] Univ Manitoba, Fac Med, Fac Pharm, Dept Pharmacol & Therapeut,Dept Internal Med, Winnipeg, MB, Canada
来源：
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY | 2005年 / 12卷 / 01期
基金：
英国医学研究理事会; 美国国家卫生研究院;
关键词：
Aging; drug disposition; CSCP Senior Investigator Award;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Dr. Dan Sitar was the recipient of the 2004 CSCP Senior Investigator Award at the First Canadian Therapeutics Congress held in June 2004. He presented a lecture highlighting some of the studies he participated in that have contributed to an increased understanding of the role of aging on drug disposition and effect.
引用
收藏
页码：E28 / E32
页数：5
相关论文
共 16 条
[1]   AMANTADINE KINETICS IN HEALTHY ELDERLY MEN - IMPLICATIONS FOR INFLUENZA PREVENTION [J].
AOKI, FY ;
SITAR, DS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) :137-144
[2]   AGING AND HEAVY DRUG-USE - A PRESCRIPTION SURVEY IN MANITOBA [J].
AOKI, FY ;
HILDAHL, VK ;
LARGE, GW ;
MITENKO, PA ;
SITAR, DS .
JOURNAL OF CHRONIC DISEASES, 1983, 36 (01) :75-84
[3]   CLINICAL PHARMACOKINETICS OF AMANTADINE HYDROCHLORIDE [J].
AOKI, FY ;
SITAR, DS .
CLINICAL PHARMACOKINETICS, 1988, 14 (01) :35-51
[4]   Population pharmacokinetics of fentanyl in healthy volunteers [J].
Ariano, RE ;
Duke, PC ;
Sitar, DS .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (07) :757-763
[5]  
Bras APM, 2001, DRUG METAB DISPOS, V29, P676
[6]   GENDER AND AGE AS FACTORS IN THE INHIBITION OF RENAL CLEARANCE OF AMANTADINE BY QUININE AND QUINIDINE [J].
GAUDRY, SE ;
SITAR, DS ;
SMYTH, DD ;
MCKENZIE, JK ;
AOKI, FY .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (01) :23-27
[7]   DRUG-ASSOCIATED HOSPITAL ADMISSIONS IN OLDER MEDICAL PATIENTS [J].
GRYMONPRE, RE ;
MITENKO, PA ;
SITAR, DS ;
AOKI, FY ;
MONTGOMERY, PR .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1988, 36 (12) :1092-1098
[8]  
Kolbe Faron, 2003, Can J Clin Pharmacol, V10, P119
[9]   SLOW RELEASE THEOPHYLLINE DISPOSITION AND EFFECT IN ELDERLY PATIENTS WITH CHRONIC OBSTRUCTIVE LUNG-DISEASE - INFLUENCE OF DOSE FORMULATION AND INSTITUTIONALIZATION [J].
MONTGOMERY, PR ;
AOKI, FY ;
MITENKO, PA ;
VANZIELEGHEM, M ;
SITAR, DS .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1989, 10 (05) :481-488
[10]   MORPHINE ANALYSIS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
OWEN, JA ;
SITAR, DS .
JOURNAL OF CHROMATOGRAPHY, 1983, 276 (01) :202-207
12